Literature DB >> 16832552

Tumor-infiltrating CD4+ T lymphocytes in early breast cancer reflect lymph node involvement.

Alexandre Henrique Macchetti1, Heitor Ricardo Cosiski Marana, João Santana Silva, Jurandyr Moreira de Andrade, Alfredo Ribeiro-Silva, Sérgio Bighetti.   

Abstract

BACKGROUND: The role of immune system in the pathogenesis and progression of breast cancer is a subject of controversy, and this stimulated us to investigate the association of the immunophenotype of tumor-infiltrating lymphocytes in early breast cancer with the spread of tumor cells to axillary lymph nodes.
METHODS: Tumor samples from 23 patients with early breast cancer from the Department of Gynecology and Obstetrics of Ribeirão Preto Medical School (USP) were obtained at the time of biopsy and submitted to an enzyme-digestion procedure for the extraction of tumor-infiltrating lymphocytes. The lymphocytes extracted were analyzed by dual-color flow cytometry with monoclonal antibodies in these combinations: CD3 FITC/CD19 PE, CD3 FITC/CD4 PE, CD3 FITC/CD8 PE, and CD16/56 PerCP, which are specific for immunophenotyping of T and B lymphocytes, helper and cytotoxic T lymphocytes, and natural killer (NK) cells. The mean percentage of these cells was used for comparing groups of patients with or without lymph node metastasis.
RESULTS: The mean value for T-lymphocyte infiltration was 24.72 +/- 17.37%; for B-lymphocyte infiltration, 4.22 +/- 6.27%; for NK-cell infiltration, 4.41 +/- 5.22%, and for CD4(+) and CD8(+) T-lymphocyte infiltration, 12.43 +/- 10.12% and 11.30 +/- 15.09%, respectively. Only mean values of T- and CD4(+) T-lymphocyte infiltration were higher in the group of patients with lymph node metastasis, while no differences were noted in the other lymphocyte subpopulations.
CONCLUSION: The association of tumor-infiltrating CD4(+) T lymphocytes with lymph node metastasis suggests a role for these cells in the spread of neoplasia to lymph nodes in patients with early breast cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16832552     DOI: 10.1590/s1807-59322006000300004

Source DB:  PubMed          Journal:  Clinics (Sao Paulo)        ISSN: 1807-5932            Impact factor:   2.365


  14 in total

1.  Capturing and characterizing immune cells from breast tumor microenvironment: an innovative surgical approach.

Authors:  Mohamed El-Shinawi; Sayed F Abdelwahab; Maha Sobhy; Mohamed A Nouh; Bonnie F Sloane; Mona Mostafa Mohamed
Journal:  Ann Surg Oncol       Date:  2010-03-24       Impact factor: 5.344

2.  Leukocyte composition of human breast cancer.

Authors:  Brian Ruffell; Alfred Au; Hope S Rugo; Laura J Esserman; E Shelley Hwang; Lisa M Coussens
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

3.  Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow.

Authors:  Anthony Lucci; Savitri Krishnamurthy; Balraj Singh; Isabelle Bedrosian; Funda Meric-Bernstam; James Reuben; Kristine Broglio; Kailash Mosalpuria; Ashutosh Lodhi; Laura Vincent; Massimo Cristofanilli
Journal:  Breast Cancer Res Treat       Date:  2008-07-29       Impact factor: 4.872

4.  Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates.

Authors:  Alessandra Estrela-Lima; Márcio S S Araújo; João M Costa-Neto; Andréa Teixeira-Carvalho; Stella M Barrouin-Melo; Sergio V Cardoso; Olindo A Martins-Filho; Rogéria Serakides; Geovanni D Cassali
Journal:  BMC Cancer       Date:  2010-06-04       Impact factor: 4.430

5.  Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers.

Authors:  Raoul Droeser; Inti Zlobec; Ergin Kilic; Uwe Güth; Michael Heberer; Giulio Spagnoli; Daniel Oertli; Coya Tapia
Journal:  BMC Cancer       Date:  2012-04-03       Impact factor: 4.430

Review 6.  A role for T-lymphocytes in human breast cancer and in canine mammary tumors.

Authors:  Maria Isabel Carvalho; Isabel Pires; Justina Prada; Felisbina L Queiroga
Journal:  Biomed Res Int       Date:  2014-02-02       Impact factor: 3.411

Review 7.  New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms.

Authors:  Meng Shen; Jian Wang; Xiubao Ren
Journal:  Front Immunol       Date:  2018-03-08       Impact factor: 7.561

8.  Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors.

Authors:  Maria Isabel Carvalho; Isabel Pires; Marlene Dias; Justina Prada; Hugo Gregório; Luis Lobo; Felisbina Queiroga
Journal:  Anal Cell Pathol (Amst)       Date:  2015-08-05       Impact factor: 2.916

9.  Development of automated quantification methodologies of immunohistochemical markers to determine patterns of immune response in breast cancer: a retrospective cohort study.

Authors:  Carlos López; Cristina Callau; Ramon Bosch; Anna Korzynska; Joaquín Jaén; Marcial García-Rojo; Gloria Bueno; Ma Teresa Salvadó; Tomás Álvaro; Montse Oños; María del Milagro Fernández-Carrobles; Montserrat Llobera; Jordi Baucells; Guifré Orero; Marylène Lejeune
Journal:  BMJ Open       Date:  2014-08-04       Impact factor: 2.692

10.  CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes.

Authors:  Wei Hseun Yeap; Kok Loon Wong; Noriko Shimasaki; Esmeralda Chi Yuan Teo; Jeffrey Kim Siang Quek; Hao Xiang Yong; Colin Phipps Diong; Antonio Bertoletti; Yeh Ching Linn; Siew Cheng Wong
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.